In COVID-19 clinical update #107, Daniel Griffin reviews vaccine booster doses, at-home testing, transmission in ferrets, improving indoor air quality, trials of BCG, ivermectin, and fluvoxamine, vaccination during pregnancy, mRNA vaccines and Fc functions, anti-platelet and aspirin therapy and a trial of prone positioning.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• FDA authorizes second booster (FDA)
• Second booster and mortality (Res Square)
• Booster effectiveness vs hospitalization (MMWR)
• SARS-CoV-2 confections (Lancet)
• At-home testing (MMWR)
• Transmission study in ferrets (PLoS Path)
• Improving indoor air quality (EPA)
• BCG vaccine no effect on viral infections (Clin Inf Dis)
• Vaccination during pregnancy (JAMA)
• mRNA vaccines and different Fc functions (Sci Transl Med)
• Ivermectin clinical trial (NEJM)
• Fluvoxamine clinical trial (Lancet)
• Antiplatelet therapy (JAMA)
• Aspirin and in-hospital mortality (JAMA)
• Proning trial (Brit Med J)
• Dr. Griffin's treatment guide (pdf)
• Contribute to ASTMH fundraiser at PWB 41:20
• Letters read on TWiV 883
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]